Abstract The World Health Organization's CHOosing Interventions that are Cost Effective
(WHO-CHOICE) thresholds for averting a disability-adjusted life-year of one to three times …

Abstract The World Health Organization (WHO) recommends that the cost-effectiveness (CE)
of introducing new vaccines be considered before such a programme is implemented …

Many countries use the cost–effectiveness thresholds recommended by the World Health
Organization's Choosing Interventions that are Cost–Effective project (WHO-CHOICE) when …

BACKGROUND: Public health interventions that prevent mortality and morbidity have greatly
increased over the past decade. Immunization is one of these preventive interventions, with …

Background Low-and middle-income countries (LMICs) face a number of challenges in
implementing cervical cancer prevention programmes that do not apply in high-income …

Low-and middle-income countries need to consider economic issues such as cost-
effectiveness, affordability and sustainability before introducing a program for human …

Introduction Estimating the value of providing effective healthcare interventions in a country
requires an assessment of whether the improvement in health outcomes they offer exceeds …

Traditional EPI vaccines are considered to be among the most efficient uses of scarce health
care resources. Today, there are many under-used and new vaccines available. In the short …

This report provides recommendations for budget holders and decision makers in high-,
middle, and low-income countries requiring economic analyses of new vaccination …

Background: Cost-effectiveness analysis (CEA) is the economic analysis method most
commonly applied today in the context of replacing one treatment with a new one in a …